Related references
Note: Only part of the references are listed.High BM plasma S100A8/A9 is associated with a perturbed microenvironment and poor prognosis in myelodysplastic syndromes
Yu-Hung Wang et al.
BLOOD ADVANCES (2023)
The immune landscape in BCR-ABL negative myeloproliferative neoplasms: inflammation, infections and opportunities for immunotherapy
Marie Strickland et al.
BRITISH JOURNAL OF HAEMATOLOGY (2022)
Megakaryocytes Are Regulators of the Tumor Microenvironment and Malignant Hematopoietic Progenitor Cells in Myelofibrosis
Lilian Varricchio et al.
FRONTIERS IN ONCOLOGY (2022)
Bone marrow stroma cells promote induction of a chemoresistant and prognostic unfavorable S100A8/A9high AML cell subset
Martin Boettcher et al.
BLOOD ADVANCES (2022)
The Genomic Landscape in Philadelphia-Negative Myeloproliferative Neoplasm Patients with Second Cancers
Chia-Chen Hsu et al.
CANCERS (2022)
Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms
Juan Ibarra et al.
BLOOD CANCER DISCOVERY (2022)
Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis
Nils B. Leimkuhler et al.
CELL STEM CELL (2021)
Myeloproliferative Neoplasm-Associated Type 2 Calreticulin Mutations Differentially Activate and Depend on the ATF6 Pathway of the UPR
Nicole S. Arellano et al.
BLOOD (2021)
Pathogenic Roles of S100A8 and S100A9 Proteins in Acute Myeloid and Lymphoid Leukemia: Clinical and Therapeutic Impacts
Julie Mondet et al.
MOLECULES (2021)
RAS Mediates BET Inhibitor-Endued Repression of Lymphoma Migration and Prognosticates a Novel Proteomics-Based Subgroup of DLBCL through Its Negative Regulator IQGAP3
Chih-Cheng Chen et al.
CANCERS (2021)
Still a burning question: the interplay between inflammation and fibrosis in myeloproliferative neoplasms
Helene F. E. Gleitz et al.
CURRENT OPINION IN HEMATOLOGY (2021)
Molecular heterogeneity unravelled by single-cell transcriptomics in patients with essential thrombocythaemia
Chia-Chen Hsu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Palmitoylated Proteins on AML-Derived Extracellular Vesicles Promote Myeloid-Derived Suppressor Cell Differentiation via TLR2/Akt/mTOR Signaling
Sehmus Tohumeken et al.
CANCER RESEARCH (2020)
Mutant Calreticulin in the Myeloproliferative Neoplasms
Daniel Prins et al.
HEMASPHERE (2020)
Mayo CALR mutation type classification guide using alpha helix propensity
Terra L. Lasho et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms
Marijana Kovacic et al.
CELLULAR ONCOLOGY (2018)
Aberrant let7a/HMGA2 signaling activity with unique clinical phenotype in JAK2-mutated myeloproliferative neoplasms
Chih-Cheng Chen et al.
HAEMATOLOGICA (2017)
Aberrant let7a/HMGA2 signaling activity with unique clinical phenotype in JAK2-mutated myeloproliferative neoplasms
Chih-Cheng Chen et al.
HAEMATOLOGICA (2017)
Alarmin S100A8 Activates Alveolar Epithelial Cells in the Content of Acute Lung Injury in a TLR4-Dependent Manner
Deblina Chakraborty et al.
FRONTIERS IN IMMUNOLOGY (2017)
Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants
Ilyas Chachoua et al.
BLOOD (2016)
Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis
Caroline Marty et al.
BLOOD (2016)
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms
D. Pietra et al.
LEUKEMIA (2016)
Loss of Ezh2 cooperates with Jak2V617F in the development of myelofibrosis in a mouse model of myeloproliferative neoplasm
Yue Yang et al.
BLOOD (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Mesenchymal Inflammation Drives Genotoxic Stress in Hematopoietic Stem Cells and Predicts Disease Evolution in Human Pre-leukemia
Noemi A. Zambetti et al.
CELL STEM CELL (2016)
S100A8/A9: From basic science to clinical application
Monika Pruenster et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Δ9-Tetrahydrocannabinol-mediated epigenetic modifications elicit myeloid-derived suppressor cell activation via STAT3/S100A8
Jessica Margaret Sido et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution
X. Cabagnols et al.
LEUKEMIA (2015)
Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients
Ayalew Tefferi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact
A. Tefferi et al.
LEUKEMIA (2014)
The evolving genomic landscape of myeloproliferative neoplasms
Jyoti Nangalia et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2014)
DNA Methylation and Its Basic Function
Lisa D. Moore et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
J. Nangalia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
Thorsten Klampfl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?
Hans Carl Hasselbalch
BLOOD (2012)
Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks
Cole Trapnell et al.
NATURE PROTOCOLS (2012)
Inflammation-associated S100 proteins: new mechanisms that regulate function
Jesse Goyette et al.
AMINO ACIDS (2011)
The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer
Jan M. Ehrchen et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Share Paper
